Get the Weekly Intelligence Brief — top committee picks every Sunday.

DNTH vs ZBH

Dianthus Therapeutics, Inc. vs Zimmer Biomet — AI-powered side-by-side comparison
DNTH
Dianthus Therapeutics, Inc.
54
Watch
VS
ZBH
Zimmer Biomet
69
Buy
MetricDNTHZBH
AI Score 54 69
Price $108.40 $97.22
P/E Ratio -834.54× 23.54×
ROE -32.9% 5.6%
Revenue Growth YoY
Gross Margin 96.0% 69.9%
Debt / Equity 0.00× 0.59×
Dividend Yield 0.0% 1.0%
RSI (14) 52.5 63.1
Beta 0.082 0.462
Expected Upside +3.7%

AI Committee View

Current Innellis committee reasoning for DNTH versus ZBH.
ZBH leads by 15 points.

ZBH scores 69/100 (Buy) versus DNTH at 54/100 (Watch).

DNTH Committee View
50% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — revenue declining -60.8% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
  • Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock — Risk
Bear Case
  • ROE of only -22.5% -- cheap may mean cheap for a reason — Value
  • Revenue declining -60.8% YoY -- this is not a growth story right now — Growth
  • MACD histogram negative -- bearish momentum — Technical
ZBH Committee View
80% agreement
5 analysts

The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend. The committee is constructive but not yet at full conviction.

Bull Case
  • Price-to-book of 1.4x is a discount to asset value — Value
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
  • Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
DNTH Full Analysis ZBH Full Analysis